Lineage Cell Therapeutics, Inc.LCTXNYSE
Loading
Cost of Revenue Over TimeExpanding
Percentile Rank86
3Y CAGR+5.1%
5Y CAGR+17.0%
Year-over-Year Change
Direct costs attributable to producing goods sold
3Y CAGR
+5.1%/yr
vs +24.6%/yr prior
5Y CAGR
+17.0%/yr
Recent deceleration
Acceleration
-19.5pp
Decelerating
Percentile
P86
Within normal range
vs 5Y Ago
2.2x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $845000.00 | +153.0% |
| 2024 | $334000.00 | -50.2% |
| 2023 | $671000.00 | -7.8% |
| 2022 | $728000.00 | -48.9% |
| 2021 | $1.43M | +270.4% |
| 2020 | $385000.00 | -6.6% |
| 2019 | $412000.00 | +36.4% |
| 2018 | $302000.00 | +79.8% |
| 2017 | $168000.00 | -53.1% |
| 2016 | $358000.00 | - |